E-MECH LIMITED

Company number 08247762 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: E-MECH LIMITED

1. Financial Health Score: A-

E-MECH Limited is in excellent financial health, demonstrating the vitality of a well-conditioned athlete rather than a patient with any chronic conditions. The company has achieved remarkable, sustained growth over the past decade, with net assets expanding more than tenfold from £202,051 in 2015 to £2,210,880 in 2024. The only factor preventing a perfect score is the elevated concentration of debtors in the asset base, which represents a potential vulnerability requiring monitoring — much like slightly elevated blood pressure in an otherwise fit individual.


2. Key Vital Signs

Heart Rate: Revenue Growth & Profitability

Metric 2024 2023 2022 Change
Net Assets £2,210,880 £1,697,755 £1,319,569 +30% YoY
Retained Earnings Growth ~£513,125 ~£378,186 ~£429,715 Strong profitability
Shareholders' Funds £2,210,880 £1,697,755 £1,319,569 Consistent equity building

Diagnosis: The company's "heart" is beating strongly. Year-over-year retained earnings growth indicates healthy, consistent profitability. The 2024 profit of approximately £513,000 represents the company's strongest year on record.

Blood Pressure: Liquidity & Working Capital

Metric 2024 2023 Interpretation
Current Assets £2,975,665 £2,400,235 Strong resource base
Current Liabilities £865,884 £813,622 Manageable obligations
Net Current Assets £2,109,781 £1,586,613 Excellent working capital
Current Ratio 3.44x 2.95x Very healthy liquidity
Cash Position £740,498 £524,310 Strong and improving

Diagnosis: Blood pressure is in the optimal range. A current ratio of 3.44x means the company has £3.44 of current assets for every £1 of current liabilities — well above the typical healthy threshold of 1.5x. Cash reserves have grown 41% year-over-year, indicating strong cash generation.

Cholesterol: Leverage & Debt Burden

Metric 2024 2023 Interpretation
Total Liabilities £865,884 £813,622 Moderate increase
Net Assets £2,210,880 £1,697,755 Strong equity base
Debt-to-Equity Ratio 0.39x 0.48x Conservative leverage
Long-term Liabilities £24,975 £42,678 Reducing
Provisions £20,700 £19,958 Stable

Diagnosis: Cholesterol levels are excellent. The debt-to-equity ratio of 0.39x means the company has nearly £2.60 of equity for every £1 of debt — a very conservative capital structure. Long-term liabilities have actually decreased, and the company is not over-leveraged.

Bone Density: Asset Composition

Asset Category 2024 Value % of Total 2023 Value % of Total
Fixed Assets £146,774 4.9% £173,778 7.2%
Stocks £178,199 6.0% £91,987 3.8%
Debtors £2,056,968 69.1% £1,783,938 74.3%
Cash £740,498 24.9% £524,310 21.8%
Total Assets £2,975,665 100% £2,400,235 100%

Diagnosis: This is the one area requiring attention. Debtors represent nearly 70% of total assets — a significant concentration risk. While this has improved slightly from 74.3% in 2023, it remains high. Think of this as having one joint carrying most of the body's weight — it works, but it's a vulnerability.


3. Diagnosis: Overall Financial Condition

Strengths (Signs of Robust Health)

1. Exceptional Growth Trajectory The company has demonstrated a remarkable compound growth story: - Net assets have grown from £202,051 (2015) to £2,210,880 (2024) - This represents a compound annual growth rate of approximately 30.7% over 9 years - Growth has been consistent, with only minor dips in 2019-2020 (likely pandemic-related)

2. Strong Cash Generation Cash reserves have transformed dramatically: - 2020: £33,742 (a low point) - 2021: £33,616 - 2022: £405,876 - 2023: £524,310 - 2024: £740,498

The company has moved from being cash-constrained to holding over £740k in cash — a transformation from "living paycheque to paycheque" to having a healthy financial cushion.

3. Profitable Operations Each year shows retained earnings growth, meaning the company is consistently profitable and retaining profits rather than distributing them. This builds financial resilience.

4. Conservative Capital Structure With minimal long-term debt (£24,975) and strong equity, the company has significant borrowing capacity should it wish to fund expansion.

Symptoms Requiring Monitoring

1. High Debtor Concentration (Elevated Risk Marker) Debtors at £2,056,968 represent 69% of total assets. This could indicate: - Long payment terms with clients - Potential collection challenges - Revenue recognition timing - Industry norms for engineering consultancy (which typically have high work-in-progress)

Note: For engineering activities (SIC 71129), high debtor levels can be normal due to milestone billing and project-based work. However, the concentration remains a risk factor.

2. Stock Increase Stocks have nearly doubled from £91,987 to £178,199 (94% increase). This warrants monitoring to ensure stock remains current and realisable.

3. Limited Capital Investment Fixed assets have decreased from £173,778 to £146,774, suggesting the company may not be investing heavily in new equipment. For an engineering firm, this could indicate either efficient asset utilisation or potential future investment needs.


4. Prognosis: Future Financial Outlook

Short-term Outlook (12 months): Excellent

The company enters 2025 with strong momentum, healthy cash reserves, and a robust balance sheet. The immediate financial health is very strong.

Medium-term Outlook (2-3 years): Very Good

The consistent growth trajectory suggests continued expansion. However, the company will need to manage: - Working capital as the business grows - Potential need for capital investment in equipment - Debtor management to maintain cash flow

Long-term Considerations

As a small company with two equal shareholders/directors, key-person risk exists. Succession planning and business continuity arrangements would be prudent.


5. Recommendations: Prescriptions for Continued Financial Wellness

Priority 1: Debtor Management (Address the Elevated Risk)

  • Review credit terms: Ensure payment terms are competitive but protective (30 days maximum where possible)
  • Implement systematic collection procedures: Regular aged debtor reviews and escalation protocols
  • Consider invoice financing: If debtor levels are structural to the business model, this could accelerate cash collection
  • Target: Reduce debtor days and aim for debtors below 60% of total assets

Priority 2: Cash Utilisation Strategy

With £740k in cash and growing, consider: - Short-term deposit accounts: Earn interest on surplus cash - Strategic investment: Evaluate whether equipment upgrades could improve operational efficiency - Pension planning: Directors should consider tax-efficient pension contributions - Emergency reserve: Maintain 3-6 months of operating expenses as a buffer

Priority 3: Fixed Asset Investment Review

  • Assess whether ageing plant and machinery needs replacement
  • Evaluate lease vs. buy decisions for any new equipment
  • Consider whether current asset levels support the growth trajectory

Priority 4: Stock Management

  • Review the 94% increase in stock levels
  • Ensure stock remains current and saleable
  • Implement just-in-time procurement where possible

Priority 5: Business Continuity Planning

  • Given the two-director structure with equal ownership, formalise shareholder agreements
  • Consider key-person insurance
  • Document succession plans

Growth Trajectory Summary

Year Net Assets YoY Growth Cash Position
2015 £202,051 £23,384
2016 £266,434 +32% £16,850
2017 £526,795 +98% £61,855
2018 £768,224 +46% £210,799
2019 £672,876 -12% £22,076
2020 £622,634 -7% £33,742
2021 £889,284 +43% £33,616
2022 £1,319,569 +48% £405,876
2023 £1,697,755 +29% £524,310
2024 £2,210,880 +30% £740,498

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 21 August 2026